-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$44.3346.16% Upside
Surgery Partners, Inc. Frequently Asked Questions
-
What analysts cover Surgery Partners, Inc.?
Surgery Partners, Inc. has been rated by research analysts at UBS, Macquarie, Citigroup in the past 90 days.